The concept of multifunctional nanomaterials has shown the most prominent progressive approach in the field of nanotechnology, which is anticipated to transform diagnosis and treatment. Gold nanoparticles (AuNPs) have fabricated a massive role in human well-being in the clinical diagnostic and therapeutic field, as well as in multiple biomedical applications. Plenty of special attributes of gold nanoparticles (AuNPs) have given them a special place in the field of biomedical applications like their biocompatibility, low toxicity, high stability, number of unique functional characteristics feature, and convenience as well as way of synthesis became reason to attract broad attention. Internal features like optical, electronic along physiochemical helped gold nanoparticles (AuNPs) to play a major part in their consideration as an effective nanomedicine contender. Gold nanoparticles (AuNPs) are now being extensively employed as theranostics due to their tunable and largely sensitive optical and physicochemical properties. The term “Theranostics,” is a multifunctional operation that contains diagnostic and therapeutic functions at the same time while integrated into one system, thereby concurrently facilitating diagnosis and therapy. In this review, the recent progress and research on gold nanoparticles (AuNPs) as theranostics applications suchlike as cancer, antimicrobial, wound care, Alzheimer’s disease, COVID-19 etc. are described.
REFERENCES
1.
O.
Esim
, S.
Kurbanoglu
, A.
Savaser
, S.
Ozkan
, Y.
Ozkan
, “Nanomaterials for drug delivery systems,” New Developments in Nanosensors for Pharmaceutical Analysis
, (Elsevier
, 2019
), pp. 273
–301
.2.
M.
Benelmekki
, “An introduction to nanoparticles and nanotechnology,” Designing Hybrid Nanoparticles
, (Morgan & Claypool Publishers
), 2014
.3.
A.H.
Faraji
, P.
Wipf
, “Nanoparticles in cellular drug delivery,” Bioorganic and Medicinal Chemistry
, (Elsevier
, 2009
), pp. 2950
–62
.4.
A. A.
Yetisgin
, S.
Cetinel
, M.
Zuvin
, A.
Kosar
, O.
Kutlu
, “Therapeutic nanoparticles, and their targeted delivery applications
,” Molecules, (MDPI AG., 2020)
, PP. 25
.5.
A.
Wilczewski
, K.
Niemirowicz
, K. H
Markiewicz
, and H Car, “Nanoparticles as drug delivery systems,” Pharmacological Reports
(Elsevier
, 2012
), pp. 1020
–1037
.6.
S.
Bose
, P.
Sharma
, V.
Mishra
, S.
Patial
, G. K.
Saraogi
, M. M.
Tambuwala
and K.
Dua
, J. Mol. Struct.
1231
, 129927
(2021
).7.
G. K.
Saraogi
, S.
Tholiya
, Y.
Mishra
, V.
Mishra
, A.
Albutti
, P.
Nayak
and M. M.
Tambuwala
. Gels.
8
(2
): 81
(2022
).8.
W.
Lohcharoenkal
, L.
Wang
, Y.C.
Chen
, and Y.
Rojanasakul
, “Protein nanoparticles as drug delivery carriers for cancer therapy,” BioMed Research International
, (Hindawi Publishing Corporation
, 2014
).9.
A.
Modi
, V.
Mishra
, A.
Bhatt
, A.
Jain
, M. H.
Mansoori
, E.
Gurnany
and V.
Kumar
, Chin. J. Nat. Med.
14
(1
):31
–39
(2016
).10.
R. P.
Moura
, F.
Sousa
, A.
Almeida
, S.
Pinto
, and B.
Sarmento
, Theranostic Bionanomaterials
, 303
–319
, (2019
).11.
12.
S. N.
Santos
, E. S.
Bernardes
, and R.
Santos-Oliveira
, Fundamentals of Nanoparticles: Classifications, Synthesis Methods, Properties and Characterization
, 553
–569
, (2018
).13.
S. H.
Shahcheraghi
, J.
Ayatollahi
, A. A.
Aljabali
, M. D.
Shastri
, S. D.
Shukla
, D. K.
Chellappan
, N. K.
Jha
, K.
Anand
, N. K.
Katari
, M.
Mehta
, S.
Satija
. Ther. Deliv.
12
(3
):235
–244
(2021
).14.
V.
Mishra
, M.
Singh
, Y.
Mishra
, N.
Charbe
, P.
Nayak
, K.
Sudhakar
, A. A.
Aljabali
, S. H.
Shahcheraghi
, H.
Bakshi
, A.
Serrano-Aroca
and M. M.
Tambuwala
, Appl. Sci.
11
(15
):7119
(2021
).15.
K.
Nejati
, M.
Dadashpour
, T.
Gharibi
, H.
Mellatyar
, and A.
Akbarzadeh
, J. Clust. Sci.
(2021
).16.
17.
V.
Saluja
, Y.
Mishra
, V.
Mishra
, N.
Giri
and P.
Nayak
, Int. J. Pharm.
600
:120485
(2021
).18.
Gold Nanoparticles: Optical Properties. (n.d.). NanoComposix Fortis Life Science. Retrieved October 9, 2021
, from https://nanocomposix.com/pages/gold-nanoparticles-optical-properties.19.
X.
Bai
, Y.
Wang
, Z.
Song
, Y.
Feng
, Y.
Chen
, D.
Zhang
, and L.
Feng
, Int. J. Mol. Sci.
21
(7
), (2020
).20.
I.
Hammami
, N. M.
Abdallah
, A.
Joma
, and M.
kamoun
, J. King Saud Univ. Sci.
33
(7
), (2021a
).21.
W.
Ahmed
, A.S.
Bhatti
, and J. M.
van Ruitenbeek
, J. Nanopart. Res.
19
(3
), (2017
).22.
M.
Toro-González
, D. M.
Clifford
, M. C.
Molina
, C. E.
Castano
, and J.V.
Rojas
, Radiat. Phys. Chem.
188
(2021
).23.
IEEE Nanotechnology Council, & Institute of Electrical and Electronics Engineers
. “Two-Phase Brust-Schiffrin Synthesis of Gold Nanoparticles Dispersion in Organic Solvent on Glass Microfluidic Device
,” IEEE NANO 2017: 17th International Conference on Nanotechnology
, (Pittsburgh, USA
), 2017
.24.
J.
Dong
, P. L.
Carpinone
, G.
Pyrgiotakis
, P.
Demokritou
, and B.M.
Moudgil
, KONA Powder Part. J.
(2020
).25.
F. J. Flórez
Barajas
, Z. C. Sánchez
Acevedo
, and H. Peña
Pedraza
, Respuestats
, 24
(2
), 49
–55
(2019
).26.
M.
Gupta
, Y.
Mishra
, V.
Mishra
and M. M.
Tambuwala
, EXCLI J.
21
: 680
–686
(2022
).27.
H.
Wolfgang
, T. K.
Nguyen
, Thanh, J.
Aveyard
, & D. G.
Fernig
, “Anal. Chem
, 79
(11
), 4215
–4221
(2007
).28.
N. N.
Long
, Kiem. Vu. L, C. D.
van
, S. C.
Doanh
, C. T.
Nguyet
, P. T.
Hang
, N. D.
Thien
, and L. M.
Quynh
, Jour. Phy.: Conf.of series
, 187
, (2009
).29.
X.
Hu
, Y.
Zhang
, T.
Ding
, J.
Liu
, and H Zhao, Front. Bioeng. Biotechnol.
990
(2020b
).30.
P.
Kaur
, A.
Mittal
, S. K.
Nayak
, M.
Vyas
, V.
Mishra
and G. L.
Khatik
, Curr. Drug Targets.
19
(15
):1738
–1766
(2018
).31.
I.
Hammami
, N. M.
Abdallah
, A.
Joma
, and M.
kamoun
, J. King Saud Univ. Sci.
33
(7
), (2021b
).32.
V.
Saluja
, A.
Mankoo
, G. K.
Saraogi
, M. M.
Tambuwala
and V.
Mishra
, J. Drug Deliv. Sci. Technol.
52
:15
–26
(2019
).33.
G.
Han
, P.
Ghosh
, and V. M.
Rotello
, Nanomed.
2
(1
), 113
–125
(2007
).34.
K.
Saha
, S. S.
Agasti
, C.
Kim
, X.
Li
, and V. M.
Rotello
, “Gold Nanoparticles in Chemical and Biological Sensing
,” Chem. Rev.
112
(5
), 2739
(2012
).35.
M.
Devi
, and S.
Awasthi
, “Gold nanoparticles in drug delivery systems: Therapeutic applications
,” American institute of physics inc, AIP Conference Proceedings
, 2142
(2019
).36.
S.
Wang
, and G Lu., Noble and Precious Metals - Properties, Nanoscale Effects and Applications
, (2018
).37.
Y
Chen
, J.
Yang
, S.
Fu
, and J.
Wu
, Int. J. Nanomedicine.
15
, 9407
–9430
(2020
).38.
L. A.
Dykman
, and N. G.
Khlebtsov
, Biomed. Opt. Express.
10
(7
), 3152
(2019
).39.
J. F.
Dorsey
, L.
Sun
, D.Y.
Joh
, A.
Witztum
, A.
Zaki
, G. D.
Kao
, M.
Alonso-Basanta
, S.
Avery
, A.
Tsourkas
, and S. M.
Hahn
, Transl. Cancer Res.
2
(4
), 280
–291
(2013
).40.
P. M.
Tiwari
, S. S.
Bawage
, and S. R.
Singh
, Applications of Nanoscience in Photomedicine
, 249
–266
(2015
).41.
42.
A.
Das
, and S.
Patra
, Nanostructures for Antimicrobial Therapy: Nanostructures in Therapeutic Medicine Series
, 1
–22
(2017
).43.
H.
Daraee
, A.
Eatemadi
, E.
Abbasi
, S. F.
Aval
, M.
Kouhi
, and A.
Akbarzadeh
, Artif. Cells Nanomed. Biotechnol.
44
(1
), 410
–422
(2016
).44.
45.
R. F.
Nunes
, R. M. F.
Zuppani
, A. M.
Coutinho
, F. G.
Barbosa
, M. T.
Sapienza
, J. F. G.
Marin
, and C. A.
Buchpiguel
, PET Clinics
, 16
(3
), (2021
).46.
M.
Vyas
, S.
Thakur
, B.
Riyaz
, K. K.
Bansal
, B.
Tomar
and V.
Mishra
, Asian J. Pharm.
12
(2
): 72
–76
(2018
).47.
P.
Pedrosa
, R.
Vinhas
, A.
Fernandes
, and P. V.
Baptista
, Nanomaterials
, 5
(4
), 1853
–1879
(2015
).48.
49.
S.P.C
Hsu
, U.
Dhawan
, Y. Y.
Tseng
, C. P.
Lin
, C. Y.
Kuo
, L. F.
Wang
, and R.J.
Chung
, Appl. Mat. Today
, (2020
).50.
A.
Liu
, G.
Qiao
, Y.
Han
, E.
Shen
, G.
Alfranca
, H.
Tan
, L.
Wang
, S.
Pan
, L.
Ma
, W.
Xiong
, Y.
Liu
, and D.
Cui
, Acta Biomater.
117
, 361
–373
. (2020
).51.
H.
Xu
, S.
Jiang
, J.
Wang
, X.
Li
, T.
Wu
, P.
Xu
, R.
Santos-Oliveira
, and A Zhang, Anti-Cancer Agents Med. Chem.
20
(14
), 1648
–1653
. (2020
).52.
Y. M. L.
Chen
, X.
Li
, A.
Hu
, H.
Wang
, H.
Zhou
, B.
Tian
, and J.
Dong
, Biomaterials.
275
(2021
).53.
A.
Fernandes
, D. D.
Fernandes
, A.
Malik
, G. N. W
Gomes
, S.
Appak-Baskoy
, E.
Berndl
, C. C.
Gradinaru
, and M. C.
Kolios
, J. Photochem. Photobiol. B, Biol.
218
, (2021
).54.
M. L.
Castilho
, V. P. S.
Jesus
, P. F. A.
Vieira
, K. C.
Hewitt
, and L.
Raniero
, Photodiagnosis and Photodynamic Therapy
, 33
(2021
).55.
56.
V. V.
Vodnik
, M.
Mojić
, U.
Stamenović
, M.
Otoničar
, V.
Ajdžanović
, D.
Maksimović-Ivanić
, S.
Mijatović
, M. M.
Marković
, T.
Barudžija
, B.
Filipović
, V.
Milošević
, and B.
Šošić-Jurjević
, Mater. Sci. Eng. C.
124
(2021
).57.
T.
Tangthong
, T.
Piroonpan
, V. C.
Thipe
, M.
Khoobchandani
, K.
Katti
, K. V.
Katti
, and W.
Pasanphan
, Nanotechnol. Sci. Appl.
14
, 69
–89
(2021
).58.
J.
Almowalad
, S.
Somani
, P.
Laskar
, J.
Meewan
, R. J.
Tate
, R, M.
Mullin
, and C Dufès, Int. J. Nanomed.
16
, 4391
–4407
(2021
).59.
M. S.
Lodhi
, M. T.
Khan
, S.
Aftab
, Z. Q.
Samra
, H.
Wang
, and D. Q.
Wei
, Cancer Nanotechnol.
12
(1
), 1
–27
(2021
).60.
Y.
Zhang
, J.
Tan
, L.
Zhou
, X.
Shan
, J.
Liu
, and Y.
Ma
, ACS Omega.
5
(48
), 31227
–31233
(2020
).61.
Y.
Zhang
, L.
Zhou
, J.
Tan
, J.
Liu
, X.
Shan
, and Y.
Ma
, Biomed. Pharmacother.
130
(2020
).62.
A.
Piktel
, I.
Ościłowska
, L.
Suprewicz
, J.
Depciuch
, N.
Marcińczyk
, E.
Chabielska
, P.
Wolak
, T.
Wollny
, M.
Janion
, M.
Parlinska-Wojtan
, and R.
Bucki
, Int. J. Nanomed.
16
, 1993
–2011
(2021
).63.
L.
Chuanzhi
, G.
Ping
, L.
Yuping
, W
Zuobin
, W.
Wang
, Materials Science / Medziagotyra.
243
–248
(2020
).64.
L.M.
Cucci
, G.
Trapani
, O.
Hansson
, D. la
Mendola
, C.
Satriano
, Nanomaterials.
11
(1
), 1
–27
(2021
).65.
A.
Morales-Zavala
, P.
Jara-Guajardo
, D.
Chamorro
, A. L.
Riveros
, A.
Chandia-Cristi
, N.
Salgado
, P.
Pismante
, E.
Giralt
, M.
Sánchez-Navarro
, E.
Araya
, R.
Vasquez
, G.
Acosta
, F.
Albericio
, R. A.
Alvarez
and M. J.
Kogan
, Biomater. Sci.
9
(11
), 4178
–4190
(2021
).66.
67.
A.
Wang
, W.
Ouyang
, X.
Zhang
, J.
Xue
, X.
Lou
, R.
Fan
, X.
Zhao
, L.
Shan
, and T.
Jiang
, J. Mater. Chem. B.
7
(30
), 4630
–4637
(2019
).
This content is only available via PDF.
©2023 Authors. Published by AIP Publishing.
2023
Author(s)
You do not currently have access to this content.
